Shuli Ren, Columnist

Alibaba Incubates a Health Risk for Investors

Its online pharmacy unit is showing signs of contagious stock fever.

June 5, 2018 at 2:30 AM UTC

Shuli Ren is a Bloomberg Opinion columnist covering Asian markets. A former investment banker, she was a markets reporter for Barron’s. She is a CFA charterholder.

Ali Health shares are hot, surging 58 percent in two weeks.
Photographer: Wanhao Cai/iStockphoto/Getty Images

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Jack Ma just sowed the seed of another decacorn – a startup worth more than $10 billion – on the Hong Kong stock exchange.

Largely ignored by analysts, Alibaba Group Holding Ltd.’s health unit suddenly woke from a long hibernation last month, soaring 58 percent in two weeks to reach a market value of $8.7 billion. Most of the rally came before Alibaba Health Information Technology Ltd. announced the $1.4 billion purchase of healthcare assets from its parent.